Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Squalamine Lactate + Ranibizumab in Diabetic Macular Edema
NCT02349516Phase 2Withdrawn
- Start
- Feb 2015
- Primary completion
- Sep 2015
- Modality
- Multivalent & Scaffold-Based Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of squalamine in diabetic macular edema (DME). Planned start Feb 2015; status: withdrawn.
02
Drugs
squalamine
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02349516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349516.